SCLX: Scilex Holding Company Stock

by  •  • Comments Off on SCLX: Scilex Holding Company Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 59.35
Enterprise Value ($M) 158.24
Book Value ($M) -211.32
Book Value / Share -1.15
Price / Book -0.28
NCAV ($M) -271.89
NCAV / Share -1.48
Price / NCAV -0.22

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.87
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.13
Current Ratio 0.14

Balance Sheet (mrq) ($M)
Current Assets 39.85
Assets 100.43
Liabilities 311.75
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-23 13D/A SCLX Stock Acquisition JV LLC 21.10
01-17 13G Oramed Pharmaceuticals Inc. 6.20

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 388,232 1,122,574 34.58
2025-03-06 674,354 1,941,607 34.73
2025-03-05 377,093 1,209,726 31.17
2025-03-04 690,294 1,773,614 38.92

(click for more detail)

Similar Companies
SABS – SAB Biotherapeutics, Inc. SAVA – Cassava Sciences, Inc.
SBFM – Sunshine Biopharma, Inc. SGMO – Sangamo Therapeutics, Inc.
SHPH – Shuttle Pharmaceuticals Holdings, Inc.


Financial data and stock pages provided by
Fintel.io